A Controlled Clinical-Trial On The Cardiovascular Effects Of Single Doses Of Pseudoephedrine In Hypertensive Patients
UTSePress Research/Manakin Repository
JavaScript is disabled for your browser. Some features of this site may not work without it.
- UTSePress Research Home
- >
- 11 Medical and Health Sciences
- >
- Journal Articles
- >
- Closed
- >
- View Item
| dc.contributor.author | Chua Ss | en_US |
| dc.contributor.author | Benrimoj Charlie | en_US |
| dc.contributor.author | Gordon Rd | en_US |
| dc.contributor.author | Williams G | en_US |
| dc.contributor.editor | en_US | |
| dc.date.accessioned | 2012-02-02T11:01:27Z | |
| dc.date.available | 2012-02-02T11:01:27Z | |
| dc.date.issued | 1989 | en_US |
| dc.identifier | 2010000852 | en_US |
| dc.identifier.citation | Chua Ss et al. 1989, 'A Controlled Clinical-Trial On The Cardiovascular Effects Of Single Doses Of Pseudoephedrine In Hypertensive Patients', Blackwell Science Ltd, vol. 28, no. 3, pp. 369-372. | en_US |
| dc.identifier.issn | 0306-5251 | en_US |
| dc.identifier.other | C1 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10453/15647 | |
| dc.description.abstract | Twenty hypertensive patients received single oral doses of pseudoephedrine 60 mg or placebo in a double-blind, randomised, crossover trial. Systolic, diastolic, mean arterial blood pressure, and heart rate were measured at 5 min intervals for 30 min prior to and 210 min after the administration of pseudoephedrine or placebo. Statistically significant differences between the two treatments were observed with changes in systolic blood pressure (P < 0.03) and heart rate (P < 0.01) but not in diastolic (P > 0.03) and mean arterial blood pressure (P > 0.1). Minor differences in the number of reported side effects between the two treatments were not statistically significant. | en_US |
| dc.language | en_US | |
| dc.publisher | Blackwell Science Ltd | en_US |
| dc.relation.isbasedon | NA | en_US |
| dc.title | A Controlled Clinical-Trial On The Cardiovascular Effects Of Single Doses Of Pseudoephedrine In Hypertensive Patients | en_US |
| dc.parent | British Journal Of Clinical Pharmacology | en_US |
| dc.journal.volume | 28 | en_US |
| dc.journal.number | 3 | en_US |
| dc.publocation | Oxford | en_US |
| dc.identifier.startpage | 369 | en_US |
| dc.identifier.endpage | 372 | en_US |
| dc.cauo.name | SCI.Medical and Molecular Biosciences | en_US |
| dc.conference | Verified OK | en_US |
| dc.for | 111500 | en_US |
| dc.personcode | 0000065728;111638;0000065729;0000065731 | en_US |
| dc.percentage | 000100 | en_US |
| dc.classification.name | Pharmacology and Pharmaceutical Sciences | en_US |
| dc.classification.type | FOR-08 | en_US |
| dc.edition | en_US | |
| dc.custom | en_US | |
| dc.date.activity | en_US | |
| dc.location.activity | ISI:A1989AN88900020 | en_US |
| dc.description.keywords | pseudoephedrine, hypertensive patients, blood pressure, nasal decongestants | en_US |
| dc.staffid | University of Sydney | en_US |
